ClinicalTrials.gov
ClinicalTrials.gov Menu

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01391962
Recruitment Status : Recruiting
First Posted : July 12, 2011
Last Update Posted : March 21, 2018
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )